Clinical trial
Rapid Antidepressant Effects of Ketamine in Major Depression
NCT00088699 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00088699 |
|---|---|
| Title | Rapid Antidepressant Effects of Ketamine in Major Depression |
| Official title | Investigation of the Rapid (Next Day) Antidepressant Effects of an NMDA Antagonist |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Depression, Mood Disorders, Major Depresssion |
| Intervention type | Drug |
| Interventions | Ketamine, Placebo |
| Enrollment | 67 |
| Start date | Jul 26, 2004 |
| Primary completion | Jul 31, 2017 |
| Completion | Jul 31, 2017 |
| First posted | Aug 2, 2004 |
| Last update posted | Oct 12, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: